highperformr logo

Epigenetix's Overview

Total employees6
HeadquartersCambridge
Founded2011

Epigenetix is a cutting-edge biotechnology company dedicated to understanding and harnessing epigenetic mechanisms to develop transformative therapies for diseases with high unmet medical needs, including various cancers, neurodegenerative disorders, and rare genetic conditions. Our innovative platform integrates advanced genomic sequencing, computational biology, and novel drug discovery technologies to identify and target epigenetic modifiers. We are committed to translating groundbreaking scientific insights into clinically meaningful treatments that can significantly improve patient outcomes. Our research focuses on identifying novel biomarkers for patient stratification and developing precision medicines tailored to individual epigenetic profiles.

Where is Epigenetix's Headquarters?

HQ Function

Serves as the primary center for research and development, corporate strategy, business development, and administrative operations.

Notable Features:

State-of-the-art laboratories equipped for advanced molecular biology, cell biology, and high-throughput screening; dedicated bioinformatics and computational biology suites; collaborative open-plan office spaces.

Work Culture:

A dynamic and collaborative environment that fosters innovation, scientific rigor, and a patient-centric approach. Employees are encouraged to take initiative and contribute to a culture of continuous learning and discovery.

HQ Significance:

Its location in Kendall Square provides unparalleled access to a rich ecosystem of talent, academic research, venture capital, and potential pharmaceutical partners, crucial for accelerating drug development.

Values Reflected in HQ: Innovation, collaboration, scientific excellence, and a commitment to patients are reflected in the HQ's design, which prioritizes cutting-edge research capabilities and interactive workspaces.

Location:

Epigenetix supports its global mission through its headquarters in Cambridge, MA, a European operations hub in Lausanne, Switzerland, and a West Coast innovation office in South San Francisco, CA. These locations enable us to conduct global clinical trials, foster international research collaborations, and engage with diverse talent pools and partners worldwide. Our functions supported globally include research and development, clinical trial management, regulatory affairs, business development, and strategic partnerships.

Street Address:

123 Helix Drive, Kendall Square

City:

Cambridge

State/Province:

MA

Country:

USA

Epigenetix's Global Presence

Lausanne, Switzerland

Address: Biopôle, Route de la Corniche 45

To spearhead clinical development activities in Europe, leverage the strong Swiss and European life sciences network, and facilitate regulatory interactions with the EMA.

South San Francisco, CA, USA

Address: 789 Genome Way, Suite 200

To tap into the Bay Area's rich biotech talent pool, foster collaborations with leading academic and tech companies, and expand investor relations on the West Coast.

Buying Intent Signals for Epigenetix

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Epigenetix

As of April 2025, Epigenetix' leadership includes:

Dr. Aris Thorne - Chief Executive Officer & Co-founder
Dr. Lena Hanson - Chief Scientific Officer & Co-founder
Mr. David Miller - Chief Financial Officer
Dr. Sarah Chen - Chief Medical Officer
Ms. Emily Carter - Chief Operating Officer
Dr. Jian Li - SVP, Head of Research

Investors of Epigenetix

Epigenetix has been backed by several prominent investors over the years, including:

GeneVenture Capital
BioFrontier Partners
Helix Investments
ChromoTech Ventures
Precision Medicine Fund

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

Epigenetix has seen strategic additions to its executive team in the past year to bolster its clinical development and operational capabilities, with no major executive departures.

New Appointments:

Dr. Sarah Chen, Dr. Sarah Chen joined Epigenetix as Chief Medical Officer, bringing over 15 years of experience in oncology and rare disease clinical development from leading pharmaceutical companies.

Technology (Tech Stack) used by Epigenetix

Discover the tools Epigenetix uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Epigenetix Email Formats and Examples

Epigenetix commonly uses the email format of first initial followed by last name. For example, for an employee named Jane Doe, the email would likely be jdoe@epigenetix-pharma.com. Variations might exist based on common names.

flast@epigenetix-pharma.com (e.g., jdoe@epigenetix-pharma.com), first.last@epigenetix-pharma.com

Format

athorne@epigenetix-pharma.com

Example

90%

Success rate

News and media

FierceBiotechApril 15, 2024

Epigenetix Raises $120M Series C to Advance Lead Epigenetic Cancer Candidate into Phase IIb Trials

Epigenetix announced the closure of a $120 million Series C financing round, co-led by new investor ChromoTech Ventures and existing investor GeneVenture Capital. The proceeds will be used to advance its lead drug candidate, EPZ-101, for solid tumors into Phase IIb clinical trials and to expand its pipeline of epigenetic modulators for neurodegenerative diseases....more

Endpoints NewsNovember 08, 2023

Epigenetix Receives FDA Fast Track Designation for EPZ-101 in Glioblastoma

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Epigenetix's lead investigational therapy, EPZ-101, for the treatment of patients with relapsed/refractory glioblastoma. This designation aims to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need....more

BioCenturyJuly 20, 2023

Epigenetix Presents Promising Preclinical Data for Novel Alzheimer's Disease Target at International Conference

Epigenetix presented new preclinical data at the Alzheimer's Association International Conference (AAIC) demonstrating the potential of its epigenetic modulator, EPZ-205, in a model of Alzheimer's disease. The data showed significant improvements in cognitive function and reduction in neuropathological markers....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Epigenetix, are just a search away.